Search results

53 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Jill Dowen
Jill Dowen, PhD, is a UNC Lineberger Comprehensive Cancer Center member and Assistant Professor in the Biochemistry and Biophysics Department and the Biology Department at UNC-Chapel Hill. Dr. Dowen's lab is investigating the function of DNA loops involving genes and their regulatory elements.
Located in People
Located in Newsroom / UNC Lineberger in the News
Located in Newsroom / UNC Lineberger in the News
Located in Newsroom / UNC Lineberger in the News
Roger Johnson
Siler City native Roger Johnson knows the value of personalized medicine. After being diagnosed with bladder cancer in 2013, physicians at UNC sequenced his tumor to better understand the genetics driving his cancer.
Located in Patient Stories / Patient Stories Gallery / Bladder Cancer
All the Cell’s a Stage
Brian Strahl, PhD, and his band of biochemists unravel the complicated mysteries of the epigenetic code to find a culprit in cancer development.
Located in News
UNC researchers find final pieces to the circadian clock puzzle
Sixteen years after scientists found the genes that control the circadian clock in all cells, the lab of UNC’s Aziz Sancar, MD, PhD, discovered the mechanisms responsible for keeping the clock in sync.
Located in News
Mauro Calabrese
Mauro Calabrese, PhD, is a UNC Lineberger Comprehensive Cancer Center member and Assistant Professor at UNC-Chapel Hill in the Department of Pharmacology. Calabrese Lab focuses on Genomics.
Located in People
Largest cancer genetic analysis reveals new way of classifying cancer
Researchers with The Cancer Genome Atlas (TCGA) Research Network have completed the largest, most diverse tumor genetic analysis ever conducted, revealing a new approach to classifying cancers. The work, led by researchers at the UNC Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill and other TCGA sites, not only revamps traditional ideas of how cancers are diagnosed and treated, but could also have a profound impact on the future landscape of drug development.
Located in News
UNC-developed tools improve accuracy of cancer DNA sequencing
The ability of researchers and physicians to use DNA sequencing to pinpoint the genetic mutations that cause cancer has led to greater understanding of the causes of the disease and development of drugs that treat tumors by targeting specific mutations. A pair of papers published by researchers at the UNC Lineberger Comprehensive Cancer Center reveal new tools that can improve the accuracy of tumor sequencing.
Located in News